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Abstract
Changes in nuclear morphology occur during normal development and have been observed during the progression of
several diseases. The shape of a nucleus is governed by the balance of forces exerted by nuclear-cytoskeletal contacts and
internal forces created by the structure of the chromatin and nuclear envelope. However, factors that regulate the balance
of these forces and determine nuclear shape are poorly understood. The SWI/SNF chromatin remodeling enzyme ATPase,
BRG1, has been shown to contribute to the regulation of overall cell size and shape. Here we document that immortalized
mammary epithelial cells show BRG1-dependent nuclear shape changes. Specifically, knockdown of BRG1 induced grooves
in the nuclear periphery that could be documented by cytological and ultrastructural methods. To test the hypothesis that
the observed changes in nuclear morphology resulted from altered tension exerted by the cytoskeleton, we disrupted the
major cytoskeletal networks and quantified the frequency of BRG1-dependent changes in nuclear morphology. The results
demonstrated that disruption of cytoskeletal networks did not change the frequency of BRG1-induced nuclear shape
changes. These findings suggest that BRG1 mediates control of nuclear shape by internal nuclear mechanisms that likely
control chromatin dynamics.
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Introduction
The SWI/SNF complexes comprise a family of ATP-dependent
chromatin remodeling enzymes that utilize the energy released
from ATP hydrolysis to break or destabilize histone-DNA contacts
on the nucleosome [1,2]. Numerous structural alterations are
possible following SWI/SNF mediated remodeling [3,4]. The
functional consequence of these chromatin structure changes is
increased accessibility of regulatory and enzymatic proteins that
modulate chromatin assembly, DNA replication, repair and
recombination, and transcription [3]. SWI/SNF complexes are
evolutionarily conserved in eukaryotes and contain either BRM
(Brahma) or BRG1 (Brahma-related gene 1) as an essential
ATPase subunit [5–7]. SWI/SNF complexes include other
proteins known as BRG1 and BRM-associated factors (BAFs) that
can modulate the activity of BRM or BRG1 in a gene-specific
fashion [7].
To address the function of the SWI/SNF ATPases in normal
mammary epithelial cells, we generated inducible knockdowns of
either BRG1 or BRM in the non-tumorigenic mammary epithelial
cell MCF-10A [8]. The depletion of either ATPase subunit
decreased the rate of cell proliferation without inducing either
apoptosis or complete growth arrest in monolayer culture or in
three-dimensional reconstituted basement membrane (rBM) cul-
tures. The length of the cell cycle increased after depletion of
either SWI/SNF ATPase, indicating a role for BRG1 and BRM as
positive regulators of proliferation at all stages of the cell cycle.
These results were unexpected since mice heterozygous for the
BRG1 gene have an increased risk of mammary carcinoma [9–
11].
We report here that the depletion of BRG1, but not of BRM in
immortalized but non-transformed mammary epithelial cells
induced nuclear shape changes, including lobulation and the
development of folds in the nuclear surface. Paradoxically, these
changes in nuclear shape were similar to changes in nuclear
structure often observed in tumors [12], including breast tumors
[13,14]. Similar changes have also been observed in the
laminopathies, diseases caused by the mutation of Lamin A or
its interacting structural proteins at the nuclear periphery [15,16].
Exploration of these diseases has demonstrated the critical
importance of the architecture of the nuclear periphery, the place
where the nuclear lamina, nuclear envelope, nuclear lamina-
associated chromatin, and the cytoskeleton all intersect. Disruption
of these structures may have profound effects on cellular
mechanics and on gene expression. Multiple proteins of the
nuclear lamina and nuclear envelope bind to chromatin (reviewed
in [17]). The genes packaged in the peripheral heterochromatin
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attached to the nuclear lamina are predominantly silenced; release
of chromatin from the lamina toward the nuclear interior may
facilitate the activation of such genes [17].
Nuclear shape may be determined in part by connections
between the peripheral structures of the nucleus and the
cytoskeleton. Forces generated by the cytoskeleton would keep
the nucleus under tension at each connection, and the balance of
tensions would influence nuclear shape. The continuity between
cell surface integrins, the cytoskeleton, and the nucleus was directly
demonstrated in living endothelial cells by micromanipulation
[18]. The nucleus in differentiated cells is under tension mediated
by a pre-stressed cytoskeleton [19,20]. Early studies showed that
the intermediate filaments were connected to the nucleus in
epithelial cells where they are heteropolymers of at least two
cytokeratins [21–24], in fibroblasts where they are polymers of
vimentin [22,25], and in a subset of neurons that have
intermediate filaments containing peripherin [26]. Electron
microscopy revealed filaments of 5 to 6 nm in diameter connecting
10 nm cytokeratin filaments to the nuclear lamina [27]. Nuclear-
anchored cytokeratin filaments attach to desmosomes and to other
structures at the plasma membrane, linking the nucleus through
the intermediate filaments to the cell surface [22,24].
More recent work characterizing the molecular details of these
connections has identified the LINC (Linker of Nucleoskeleton
and Cytoskeleton) complex [28,29]. In this complex, the Nesprin
proteins located at the nuclear envelope bind to cytoskeletal
filaments, cross the outer nuclear membrane, and bind the SUN1
and SUN2 proteins in the lumen of the nuclear envelope. The
SUN proteins, which form a heterodimer, bind to lamins in the
nuclear lamina, to other proteins associated with the nuclear
lamina and inner nuclear membrane, and to the chromatin that is
located at the inner surface of the nuclear lamina. Different
members of the Nesprin protein family bind to actin filaments of
the cytoskeleton (Nesprin 1 and 2) [30,31], to plectin cross-bridges
with intermediate filaments (Nesprin 3) [32,33], or to the
microtubule associated motor protein kinesin (Nesprin 4) [34]. It
may be the plectin cross-bridges between intermediate filaments
and Nesprin 3 that were earlier observed as 5 to 6 nm short
filaments by electron microscopy [27]. The binding of Nesprins to
SUN proteins is necessary for effective force transmission between
the nucleus and cytoskeleton [35].
We initially hypothesized that the changes in nuclear shape that
were caused by reduction in BRG1 levels might arise from an
altered balance of tensions at connections between the cytoskel-
eton and the nuclear lamina, changes downstream of altered
expression of cytoskeleton or LINC complex proteins. In order to
directly test this hypothesis, we disrupted microtubules, actin
filaments, or cytokeratin filaments in MCF-10A cells engineered
with a doxycycline inducible knockdown of BRG1. Even after
each cytoskeletal disruption, nuclear profiles were significantly
altered by the reduction in BRG1 protein levels. We conclude that
the BRG1 related changes in the architecture of the nuclear
lamina, nuclear envelope, and peripheral heterochromatin are not
caused by altered tension exerted on the nucleus by the




MCF-10A cells were obtained from the Karmanos Cancer
Center (Detroit, Michigan). MCF-10A and MCF-10A derived
cells were cultured in phenol red free DMEM/F12 media
supplemented with cholera toxin, epidermal growth factor, insulin,
and hydrocortisone as described [8,36]. MDA-MB-231 [37,38]
and MDA-MB-231 derived cells were cultured in DMEM
containing 10% fetal bovine serum (Invitrogen, Carlsbad, CA).
Knockdown was induced by addition of 10 ng/ml doxycycline
(Sigma-Aldrich, St. Louis, MO).
Vectors, Lentivirus Production, and Generation of Cell
Lines
Vector generation, lentivirus production, and transduction of
cells were described [8]. Briefly, MCF-10A or MDA-MB-231 cells
were transduced with a lentivirus expressing the tTR-KRAB
repressor and ds-Red fluorescent protein and fluorescence
activated cell sorting (FACS) sorted to capture the ds-Red
expressing population of cells. These cells were subsequently
transduced with a doxycycline-inducible vector (PLVTHM;
Addgene, Cambridge, MA) expressing a non-specific shRNA or
a shRNA against either BRG1 or BRM [8] and green fluorescent
protein (GFP). FACS sorting captured the ds-Red and GFP
expressing cells, which were then verified for BRG1 or BRM
knockdown by western blot. Virus was produced using Lipofecta-
mine 2000 reagent (Invitrogen, Carlsbad, CA) in 293T cells.
siRNA Analysis in MCF-10A Cells
MCF-10A cells were independently transfected with one of
three siRNAs to BRG1 (Invitrogen #1-216547A01, #2-
216547A05, #3-21547A03) using Lipofectamine 2000 following
the manufacturer’s instructions. A control scrambled siRNA was
used (Thermo Scientific Dharmacon - 21 base pair sequence
AACAGUCGCGUUUGCGACUGG). Transfection efficiency
was monitored with a Santa Cruz control siRNA (fluorescein
conjugate)-A (sc-36869). The transfections were done in duplicate.
Media was changed 6 hours after transfection and cells were
harvested after 72 hours for Western blots and fixed for
immunofluorescence.
Western Blot Analysis
Whole cell extracts from MCF-10A derived cells were prepared
as described [8] from cells grown in the presence or absence of
doxycycline for 3 days. The supernatant was separated by SDS-
PAGE, and then transferred to nitrocellulose. MDA-MB-231
derived cells were lysed in 16PBS containing 1% NP-40, 10 mM
DTT, protease and phosphatase inhibitors cocktail (Roche,
Indianapolis, IN) for 30 min at 4uC. Whole cell lysate was
separated on a 4–20% SDS-PAGE (BioRad, Hercules, CA), and
transferred to a PVDF membrane. Primary antibodies used were
BRG1 (1:1000, de la Serna et al, 2000), HP1c (1:500, Cell
Signaling, Danvers, MA, 2619), PI3Kinase p85, H-SH2 domain
(1:1000, Millipore, Billerica, MA 06-496), GAPDH (1:50000,
Sigma-Aldrich, St. Louis, MO, G9295), and BRM (1:1000;
Abcam, Cambridge, MA, ab15597). GelQuant.NET software
provided by biochemlabsolutions.com was used to quantify
Western blots.
Papanicolaou Staining and Immunofluorescence
Papanicolaou stain was used to analyze the cell morphology of
the MCF-10A and MCF-10A derived cell lines according to the
classical method previously described [39]. Cells were grown on
cover slips in 6-well dishes, and after induction with doxycycline
for 6 days, were washed once with PBS, and then fixed by a direct
immersion in 95% ethanol. Cells were stained successively with
Haematoxylin for 60 seconds, Orange G for 30 seconds, and Eosin
Azure for 2 minutes. Cells were rinsed with ethanol between each
BRG1 Knockdown Induces Nuclear Shape Changes
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staining and given a final rinse with Xylene before mounting.
Analyses were performed with a Zeiss Axoplan optical microscope.
Cytoskeletal Filament Disruption
Cells were treated with Latrunculin B (EDM Chemicals,
Newark, NJ - 428020) at 0.2 mg/ml for 30 minutes, with Colcemid
(CalbioChem, San Diego, CA –234109) at 0.05 mg/ml for 3 hours,
or with sodium orthovanadate (Sigma-Aldrich, Saint Louis, MO –
S6508) at 0.2 mg/ml for 30 minutes. Treated cells were then
permeabilized for 10 minutes, ensuring the loss of constitutive
dsRed and GFP, and then fixed following previously published
methods [40].
Immunofluorescence
For immunofluorescence studies, the primary antibodies used
were against a-Tubulin (1:400, Sigma-Aldrich, St. Louis, MO, T-
5168), Cytokeratin 18 (1:50, Thermo-Scientific, Waltham, MA,
MS-142), swine Lamin A/C clone 638 (1:100, Gene Tex, Irvine
CA, GTX72069), HP1c(1:1000, Millipore, Billerica, MA,
MAB3450), Lamin B (1:500, Millipore, Billerica, MA, Clone
101-B7, Cytokeratin 8 (1:50, Abcam, ab2531), Emerin (1:50,
Santa Cruz Biotechnology,sc-15378), NuMA (1:40, Millipore,
Billerica, MA, 204-41), phospho-Histone H3 (Ser10),(1:1000,
Millipore, Billerica, MA, 05-598), Histone H1,(1:100, Millipore,
Billerica, MA, P10412), Histone H3 (1:100, Abcam, Cambridge,
UK, ab8580), Nesprin 1(1:50, Abcam, Cambridge, MA ab5250),
Nurim (1:50, Santa Cruz Biotechnology, Santa Cruz, CA, sc-
133262) H3K9 trimethylated (1:100, Millipore, Billerica, MA,
17625), SRm160 splicing factor clone B1C8 (1:100, Millipore,
Billerica, MA), HMGN2 (1:100, Millipore, Billerica, MA, 07252),
Paxillin (1:100, BD Biosciences, San Jose, CA, P13520/L16),
Vimentin (1:200, Sigma-Aldrich, St. Louis, MO,V-5255), and
PML (1:500, Millipore, Billerica, MA, AB1370). Appropriate
secondary antibodies (GAR-IgG-488, GAR-IgG-568, GAM-IgG-
488, GAM-IgG-568) were from Molecular Probes (Eugene, OR)
and used at 1:2000. Nuclei were counter stained with DAPI (49, 6-
diamidino-2-phenylindole) (1:4000 to 1:6000, Invitrogen, Carls-
bad, CA, D3571) and DRAQ 5 (1:2000 to 1:4000, BioStatus
Limited, Leicestershire, UK, DR50050). Actin filaments were
detected with Phalloidin-TRITC (1:1000, Sigma-Aldrich, St.
Louis, MO, P-1951). Cells were scored and micrographs were
taken using a Zeiss Axoplan optical microscope or a Leica laser
scanning confocal microscope (SP1 or SP5-II AOBS).
Quantification and Statistical Analysis
A minimum of 200 and a maximum of 1000 nuclei were scored
for each condition. Means plus or minus standard deviations are
reported. Analysis of variance was determined with a Student’s t-
test.
Electron Microscopy
Electron microscopy was performed as described [41]. MCF-
10A cells were grown on Thermanox coverslips at 37uC as
described above. Cells were then fixed in 2.5% glutaraldehyde in
either 0.1 M sodium cacodylate or Sorensen’s phosphate buffer,
pH 7.4 for 1 hour at 4uC, followed by an additional 1–2 hours at
room temperature. Samples were post-fixed in 1% osmium in the
same buffer as the fix at 4uC for 1 hour, washed, dehydrated in
graded ethanol’s, and embedded in Epon with propyleneoxide as
the transitional solvent. Some blocks were re-embedded at 90
degrees to the growth surface so that transverse sections could be
prepared and imaged. Images were taken with a Philips CM10
transmission electron microscope with an image intensified CCD
camera.
Results
Identification of BRG1-dependent Nuclear Structure
MCF-10A cells inducibly expressing a non-specific shRNA or
shRNA against BRG1 or BRM (BRG1i and BRMi) have been
previously described [8]. Western analysis for BRG1 and BRM
expression confirmed the alteration in expression of these proteins
(Figure 1A). Papanicolaou (PAP) staining is a multi-chromatic cell
staining technique used in clinical cytology [39,42,43]. The many
different colors and combinations of colors highlight many
different features of cell architecture from chromatin condensation
to cytokeratin expression. PAP staining of MCF-10A cells with
inducible reduction of BRG1 levels identified many cells with
altered nuclear shape, though there did not appear to be any
significant changes in overall cell shape or size, or nuclear size.
Irregularly shaped nuclei had clear and quantifiable features
including curves and bulges that deviated from an oval profile and
folds or invaginations in the structures of the nuclear surface.
Some were lobulated sufficiently to have a kidney shape
(Figure 1B). In contrast, oval shaped nuclei were consistently
observed in the uninduced cells with normal levels of BRG1
(Figure 1B) as well as in both uninduced and induced cells
expressing a scrambled sequence shRNA or the shRNA against
BRM (data not shown). About one-third of the nuclei in the BRG1
knockdown cells were irregularly shaped, while ,5% of the
control cells showed an irregular nuclear appearance (Figure 1C).
Less than 10% of the nuclei in the scramble control and BRM
knockdown cells were irregular in shape, and the percentage of
cells with irregular nuclei did not change in the presence of
doxycycline. The results indicate that BRG1, but not BRM, plays
a role in maintaining the normal nuclear shape.
BRG1-dependent Nuclear Grooves
Since the irregular features of nuclei in BRG1 knockdown cells
suggested structural alterations in the nuclear periphery, we
examined the morphology of the nuclear lamina. The nuclear
lamina of higher eukaryotes is a tightly woven meshwork of
filaments connected to the inner nuclear membrane. The lamina is
constructed from Lamin B proteins joined, in differentiated cells,
by Lamins A and C, which are alternatively spliced from the same
gene [44,45]. Confocal imaging of both Lamin A/C and Lamin B
revealed intensely staining nuclear grooves (arrows) in the BRG1
knockdown cells at an elevated frequency compared to the control
cells cultured in the absence of doxycycline (Figure 2A) without
any apparent difference in nuclear size. In addition to the presence
of grooves, the Lamin A/C and Lamin B staining also identified
the presence of kidney-shaped nuclei, (arrow head) as well as
nuclei with blebs (thick arrow). Enlarged images are shown in
Figure 2B. Quantification of the Lamin B stained cells indicated
that approximately 30% of the nuclei in the BRG1 knockdown
cells had grooves as compared to approximately 10% of the nuclei
in the control cells (Figure 2C). Quantification of Lamin A/C
stained cells indicated that nearly half of the nuclei showed
evidence of grooves upon BRG1 knockdown, however, the
background also rose, ranging between 15–20%. Though the
frequency of grooved nuclei in BRG1 knockdown cells varied
depending on whether the cells were stained for Lamin B or
Lamin A/C, the increase relative to background remained ,3-
fold (Figure 2C). This figure is largely consistent with the increase
in frequency of abnormally shaped nuclei observed by PAP
staining (Figure 1). We suggest that reduction of BRG1 protein
BRG1 Knockdown Induces Nuclear Shape Changes
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levels in MCF-10A mammary epithelial cells induces a deforma-
tion in nuclear shape that can be visualized by any of the three
methods utilized.
It is important to note that we observed no evidence for changes
in Lamin A/C or Lamin B levels upon BRG1 knockdown
(Figure 2A and data not shown), suggesting that the expression of
the genes encoding these proteins is not altered by the decrease in
BRG1. We also took a candidate approach to examine by
immunofluorescence staining the levels and localization of Lamin
associated proteins as well as other markers of nuclear structure.
No discernable changes in the Lamin associated proteins, Emerin,
Nesprin, and Nurim were observed, nor were any changes in the
splicing speckle component SRm160, the nuclear matrix associ-
ated nuclear mitotic apparatus protein (NUMA), or the chromatin
associated protein high molecular weight group protein N2 (data
not shown). In addition, no changes in staining against H1 or the
modified histones phospho-H3Ser10 and H3triMeK4 were noted
(data not shown).
To confirm that the observed effects on nuclear shape were
specifically due to a reduction in BRG1 levels, we introduced three
different siRNAs targeting BRG1 or a control siRNA into MCF-
10A cells. Western blot analysis indicated a greater than 90%
reduction in BRG1 protein levels following transfection of each of
the BRG1-specific siRNAs (Figure 3A). We then evaluated the
Figure 1. BRG1 knockdown in MCF-10A cells increases the frequency of irregularly shaped nuclei. (A) Western blot measuring the extent
of BRG1 and BRM knockdown. PI3 Kinase was measured as a loading control. Induction of BRG1 or BRM knockdown correlates with Doxycycline
(DOX) dependent GFP expression. (B) Representative images of irregular and regular shaped nuclei in PAP stained cells. Size bar 50 mm. (C)
Quantification of irregularly shaped nuclei in MCF-10A cells upon BRG1 or BRM knockdown. SCRAM represents the control cells expressing a
scrambled sequence shRNA. Data represent the means of 6 counts totaling a minimum of 200 (SCRAM +/2 DOX), 290 (BRG1i +/2 DOX), or 325 (BRMi
+/2 DOX) cells scored per cell line +/2 standard deviation. *** represents p,0.005 as determined by Student’s t-test.
doi:10.1371/journal.pone.0055628.g001
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Figure 2. Increased incidence of nuclear grooves occurs in BRG1 knockdownMCF-10A cells. (A) MFC-10A cells in the presence or absence
of BRG1 knockdown are shown labeled with either Lamin A/C or Lamin B. Arrows indicate grooves. Thick arrows indicate nuclear blebs. Arrowheads
indicate kidney shaped nuclei. Size bar 10 mm. (B) Representative individual confocal sections of nuclei with grooves labeled with either Lamin A/C
(center panel) or Lamin B (right and left panels). Arrows indicate grooves. Size bars 5 mm. (C) Quantification of grooved nuclei in MCF-10A cells upon
BRG1 knockdown as identified by Lamin A/C or Lamin B staining. Data represent ten counts of at least 100 nuclei scored for grooves with Lamin A/C
and three counts of at least 100 nuclei scored for grooves with Lamin B. Both are reported as means +/2 standard deviation. *** represents p,0.005
as determined by Student’s t-test.
doi:10.1371/journal.pone.0055628.g002
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transfected cells for changes in nuclear shape. Confocal imaging of
Lamin A/C confirmed the presence of nuclear grooves (arrows)
(Figure 3B). Quantification indicated that 30% to 60% of the
nuclei in cells with siRNA targeting BRG1had grooves, compared
to 5% to7% in the untransfected and control scrambled siRNA
cells (Figure 3C). This further confirms the observation that a
reduction of BRG1 protein levels in MCF-10A cells induces
nuclear shape changes.
Nuclear Structure is BRG1 Independent in Metastatic
Breast Cells
The MDA-MB-231 cell line was derived from a metastatic
breast adenocarcinoma [38]. Its karyotype is near-triploid but the
chromosome content is heterogeneous in the population of cells.
MDA-MB-231 cell nuclei are frequently irregularly shaped.
MDA-MB-231 cells inducibly expressing shRNA against BRG1
(BRG1i) or a control shRNA (SCRAM) were engineered using the
same methodology used to make the MCF-10A cells expressing
shRNA targeting BRG1 (manuscript in preparation; see methods).
To determine whether BRG1 affected nuclear structure in the
context of this metastatic breast cancer cell line, we examined
nuclei by Lamin A/C and Lamin B staining (Figure 4A–B). Oval
shaped nuclei lacking the lobes, blebs, folds, or grooves previously
described were considered ‘‘normal’’, but such nuclei were
observed in, at most, 5% of cells, and in most cases, the percentage
of regularly shaped nuclei was much lower (Figure 4C–D). Most
nuclei were characterized by prominent grooves, irregular shapes,
and/or multiple lobes (Figure 4A–B). Quantification of the
number of nuclei containing grooves or multi-lobed nuclei
indicated that about one-third contained grooves and approxi-
mately two-thirds were multi-lobed. Reduction of BRG1 levels
had no effect on the relative proportion of nuclear alterations
(Figure 4C–D). Western blot analysis confirmed the inducible
knockdown of BRG1 in these cells (Figure 4E). The Catalogue of
Somatic Mutations in Cancer (COSMIC) Cell Line Project
database indicates that the gene encoding BRG1 is not mutated
in MDA-MB-231 cells (http://cancer.sanger.ac.uk/
cancergenome/projects/cosmic/). We conclude that reduction of
BRG1 in the context of a metastatic breast cancer cell that already
shows altered nuclear morphology has no additional effect on
nuclear structure.
Detailed Examination of Nuclear Structure
Next, we determined whether there was any spatial relationship
between the nuclear grooves and peripheral heterochromatin.
Immunofluorescent staining of heterochromatin protein 1 (HP1)
indicated that heterochromatin distribution in these cells was not
altered by BRG1 knockdown and that there was no preferential
localization between HP1 and the nuclear grooves (arrows)
(Figure 5A). Despite the lack of any obvious connection between
HP1 and BRG1-dependent nuclear grooves, Western blot analysis
indicated that cells expressing the BRG1 shRNA contained a slight
reduction in HP1 protein levels (Figure 5B).
Electron microscopy was used to evaluate the ultrastructure of
MCF-10A nuclei after BRG1 knockdown. Sections were prepared
in two orientations: parallel to the growth surface and perpendic-
ular to the growth surface. The latter permitted an evaluation of
nuclear shape changes at the apical and basal surfaces of the
nucleus. This was especially important because the folds in the
nuclear lamina that we observed were often on the basal, or top,
surface of the nucleus. MCF-10A cells [41] or uninduced MCF-
10A BRG1i cells (Figure 6A and G) had regular oval shapes when
viewed in either orientation. BRG1 knockdown caused an increase
in irregularities in the structures of the nuclear periphery. In
sections perpendicular to the growth surface, nuclear shape
changes included irregularities in shape and deviations from an
oval profile (Figs. 6B and C), and grooves at the top surface of
nuclei (Figs. 6C, D, E, and F). Figure 6E presents a higher
magnification view of the groove in the nucleus of Figure 6C,
while Figure 6F presents a higher magnification view of the groove
in the nucleus of Figure 6D (see arrow). In the larger groove of
Figure 6E, five nuclear pores are visible, showing that this section
is taken near the side wall of the groove, where a more regular
profile is resumed. When imaged in sections parallel to the growth
surface (Figure 6H), many nuclei had deep lateral invaginations of
the nuclear lamina and envelope into the nuclear interior (see
arrow). These were deeper than the grooves at the apical surface of
the nucleus and sometimes terminated at or near nucleoli. These
lateral invaginations were, on average, wider in diameter than the
nucleoplasmic reticulum structures reported to connect with
nucleoli [46,47], though we cannot rule out a relationship between
the two structures. The invaginations induced by BRG1 knock-
down did resemble the nuclear invaginations that we have
reported in three dimensional reconstituted basement membrane
cultures of MCF-10A cells [41].
Evaluation of Nuclear-cytoplasmic Contacts
The nucleus is connected to the cytoskeleton through direct and
indirect contacts with actin filaments, microtubules, and interme-
diate filaments [18,21–24,27–29]. These contacts keep the nucleus
under isometric tension and are expected to be a major
determinant of nuclear shape [19,20,35]. We hypothesized that
altered and unequal tension applied to the nucleus through the
cytoskeleton could cause the BRG1 knockdown-induced changes
in nuclear profile. Therefore, disruption of the cytoskeleton may
suppress nuclear profile changes in BRG1-knockdown cells.
Latrunculins are a family of natural products and toxins
produced by sponges of the family latrunculia [48]. Latrunculin B
binds ß-Actin, preventing polymerization and, when added to
cells, it depolymerizes actin filaments [49,50]. It has specifically
been shown to disrupt the actin cytoskeleton in MCF10A cells
[51]. Figure 7A shows ß-Actin staining in control cells cultured in
the absence of doxycycline and in the presence or absence of
Latrunculin B. In the untreated cells, long continuous actin fibers
were observed throughout the cytoplasm. In treated cells the actin
fibers were clearly disrupted (Figure 7A). Latrunculin B treatment
did not, however, alter the percentage of cells showing nuclear
grooves in either the presence or absence of BRG1 knockdown
(Figure 7B).
Colcemid depolymerizes microtubules and prevents new
microtubule polymerization [52,53]. Microtubules seen in un-
treated cells were almost completely disrupted by colcemid
treatment (Figure 8A). Colcemid treatment to disrupt microtubules
did not change the frequency of grooves upon BRG1 knockdown
(Figure 8B).
The nucleus is also connected to intermediate filaments, which
in epithelial cells such as MCF-10A are heteropolymers of
cytokeratins. Sodium orthovanadate is a tyrosine phosphatase
inhibitor [54] that has been shown to induce transient and
reversible alterations in the cytokeratin filament network [55].
Orthovanadate treatment of cells disrupted both intermediate
filaments (Figure 9A-a-Tubulin) and actin filament organization
(Figure 9A-Phalloidin) and induced a rearrangement of the
microtubule network (Figure 9A–CK18). While orthovanadate
treatment caused a slight increase in the percentage of cells in the
population containing nuclear grooves, the increase occurred both
in the presence and absence of BRG1 knockdown. Differences
between untreated and treated cells were not statistically
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Figure 3. siRNA targeting of BRG1 confirms changes in nuclear shape in MCF-10A cells. (A) Western blot analysis of MCF-10A cells
transfected with three different siRNAs that target BRG1 or a control siRNA. U represents untransfected MCF-10A cells. S represents the control cells
expressing a scrambled siRNA. 1, 2, and 3 represent the three siRNAs targeting BRG1. PI3 Kinase was measured as a loading control. (B) Untransfected
MCF-10A cells, control MCF-10A cells transfected with a scrambled siRNA, and MCF-10A cells transfected with three different siRNAs targeting BRG1
were labeled with Lamin A/C. Arrows indicate grooves. Size bars 10 mm. (C) Quantification of grooved nuclei in untransfected, control, and BRG1
siRNA treated cells. Data represent at least three independent counts of at least 100 nuclei scored for grooves. Results are reported as means +/2
standard deviation. *** represents p,0.005 as determined by Student’s t-test whether the BRG1 knockdown results were compared to untransfected
or to control siRNA treated cells.
doi:10.1371/journal.pone.0055628.g003
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Figure 4. The frequency of grooved and multi-lobed nuclei in MDA-MB-231 cells is independent of BRG1. (A, B) Multiple representative
individual confocal sections of MDA-MB-231 cells with and without BRG1 knockdown are shown labeled with either Lamin A/C (A) or Lamin B (B).
SCRAM represents the control cells expressing a scrambled sequence shRNA. Nuclei were counterstained with the DNA dye DRAQ5. Arrows indicate
nuclear grooves. Thick arrows indicate multi-lobed nuclei. Size bars 10 mm. (C, D) Quantification of regular, grooved, and multi-lobed nuclei indicated
no change in MDA-MB-231 cells with or without BRG1 knockdown as determined by staining with Lamin A/C (C) or Lamin B (D). Data represent three
counts of at least 100 nuclei scored for grooves under each condition and are reported as the means +/2 standard deviation. (E) Western blot analysis
of BRG1 levels. GAPDH levels were monitored as a loading control.
doi:10.1371/journal.pone.0055628.g004
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significant, and the ratio of cells containing grooves in BRG1
knockdown cells to control cells was unchanged after orthovana-
date treatment (Figure 9B). We conclude that disruption of the
major cytoskeletal filament systems in mammary epithelial cells
does not mediate BRG1-dependent structural alterations in the
nuclear periphery.
Discussion
The Role of BRG1 in Regulating Nuclear Shape
BRG1 and BRM are the alternative ATPase subunits for SWI/
SNF chromatin remodeling enzymes [56]. Depletion of either
BRG1 or BRM causes a slow growth phenotype in non-
tumorigenic MCF-10A mammary epithelial cells [8]. We report
here that depletion of BRG1, but not of BRM, induced nuclear
shape changes in MCF-10A cells. These changes in nuclear shape
included folding in the structures at the nuclear periphery, the
nuclear lamina and envelope, and lobulation. Similar changes
have been observed in patients with laminopathies, diseases caused
by the mutation of Lamin A or its interacting structural proteins
[15,16].
The determinants of nuclear shape are poorly understood. The
nucleus in differentiated cells is under tension mediated by a pre-
stressed cytoskeleton [19,57]. The balance of forces delivered to
the nucleus in this way may account for the great variety of
nuclear shapes observed in tissues.
In this report, we tested the hypothesis that changes in nuclear
shape that follow BRG1 reduction are mediated by nuclear
tension. This hypothesis was consistent with published work on
nuclear-cytoskeletal connections and also with an intriguing
literature on the connections between BRG1 and the control of
cell size and shape. Re-introduction of BRG1 into BRG1 deficient
adenocarcinoma cell lines not only induced cell cycle arrest but
also caused the cells to assume a flatter and larger appearance with
an increased area of surface attachment [58–61]. BRG1 deficient
adenocarcinoma cells expressing an ATPase defective BRG1
induced a ‘‘flat cell’’ phenotype at a significantly reduced
frequency [58,61], suggesting that the change in cell morphology
required BRG1 enzymatic activity. The observed morphology
change was attributed to BRG1-dependent organization of actin
filaments [60]. However other studies employing inducible
expression of the same ATPase-deficient BRG1 allele in
NIH3T3-derived mouse fibroblasts reported a similar ‘‘flat cell’’
morphology that involved altered focal adhesions but apparently
normal actin organization [62]. Thus there are likely multiple
mechanisms by which BRG1 controls cell morphology. These
previous results are all consistent with the hypothesis that BRG1-
related changes in the cytoskeleton also may cause changes in
nuclear morphology. This idea is further supported by the
observation that interference with SWI/SNF enzyme function
via expression of a dominant negative, ATPase-deficient BRG1
resulted in increased nuclear size [62].
Despite the attractiveness of the working hypothesis, the results
were inconsistent, suggesting that internal nuclear mechanisms are
responsible for BRG1-mediated shape changes. The concept that
epigenetic regulators might help maintain the structural integrity
of nuclei is appealing because most of these proteins and
complexes have the capacity to alter chromatin structure and
because chromatin is mechanically coupled to the nuclear lamina.
Chromatin modifying proteins that post-translationally add or
remove methyl, acetyl, phospho, ubiquitin, or ADP-ribose groups,
among others, have an obvious potential to locally, and perhaps
globally, affect chromatin structure and organization [63]. ATP-
dependent chromatin remodeling enzymes have the capacity to
Figure 5. HP1 is not concentrated in nuclear grooves induced by knockdown of BRG1 in MCF-10A cells. (A) Representative and
matched individual confocal sections of Lamin B (green) and HP1 (red) stained cells grown in the presence or absence of doxycycline. Nuclei were
counterstained with the DNA dye DRAQ5 (blue). Arrows indicate grooves in the Lamin B and Overlay images. Arrows indicate lack of corresponding
grooves in the HP1 image. Size bar 10 mm. (B) Western blot analysis of HP1 and BRG1 levels. GAPDH levels were measured as a loading control.
doi:10.1371/journal.pone.0055628.g005
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Figure 6. The Ultrastructure of MCF-10A cells with BRG1 knockdown. Sections were prepared for electron microscopy in two orientations:
perpendicular to the growth surface (panels A to F) and parallel to the growth surface (panels G and H). Representative images of the structures
quantified in Figures 1 and 2 are shown. (A) Uninduced control MCF-10A BRG1i cells had regular oval profiles when viewed perpendicular to the
growth plane. For all cells shown in this orientation, the basal side of the cell adjacent to the growth surface is toward the bottom of the micrograph,
while the apical surface is facing up. (B) Irregular contours were induced in cells after BRG1 knockdown. (C) After BRG1 knockdown, some nuclei
developed both irregular contours and grooves in the apical surface of the nuclei. The groove in this nucleus is shown at higher magnification in
panel E. (D) Other nuclei had grooves on their apical sides but a more normal nuclear contour. Arrow indicates groove. The groove for this nucleus is
shown at higher magnification in panel F. (E) Higher magnification view of the groove in the nucleus of panel C. Five nuclear pores are visible in the
cleft of the groove. This shows that the wall of the groove is in an adjacent plane of section. (F) Higher magnification view of the groove in the
nucleus of panel D. (G) Uninduced control MCF-10A BRG1i cells had regular oval profiles when viewed parallel to the growth plane. (H) After
induction of BRG1 knockdown, these nuclei sometimes had deep invaginations of the nuclear lamina and covering envelope that projected deep into
the nuclear interiors and sometimes terminated adjacent to nucleoli. Arrow indicates groove. Size bar panel E 0.5 mm. All other size bars are 2 mm.
doi:10.1371/journal.pone.0055628.g006
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exert force. Some of this force is used to reorganize chromatin
structure by breaking histone:DNA contacts to allow nucleosome
movement along DNA, histone displacement, and/or replacement
of histones with variant histone counterparts [3]. SWI/SNF
enzymes are the prototype ATP-dependent chromatin remodelers
in higher eukaryotes; these enzymes have been shown to alter
chromatin structure both locally, as demonstrated by changes in
chromatin accessibility at target gene regulatory sequences, as well
as at a distance, as shown by a dependence on the ATPase subunit
BRG1 for intra-chromosomal looping and inter-chromosomal
interactions [64–67]. BRG1 also contributes to gene expression
and may also indirectly affect chromatin and nuclear structure by
altering the levels of chromatin components, such as the modest
changes in HP1 levels that were observed (Figure 5B). Additional
studies will be needed to address the possibility that the induced
changes in nuclear structure are due to forces internal to the
nucleus caused by changes in chromatin organization.
Nuclear Shape Changes and Connections to Cancer
Nuclear surface folds and lobulation have been observed in
cancer, including breast tumors where alterations in nuclear
structure are important diagnostic and prognostic markers [12–
14]. Despite the dependence of cancer diagnostics on microscopic
evaluation of patient biopsies, our understanding of the molecular
basis for these cellular structural changes is rather poor. In
particular, the molecular mechanisms underlying these changes in
nuclear structure remain enigmatic. Although not explained in
molecular detail, changes in the shape of nuclei in tumors have
been observed since the 18609s [68]. Irregular nuclear contours in
tumor cells often correlate with altered spatial organization of
chromatin [12]. Diagnostically useful nuclear features include
lobulation, the development of grooves, clefts, or folds, changes in
nuclear size, alterations in heterochromatin organization and
increases or decreases in the number or appearance of nucleoli.
The set of nuclear alterations observed clinically is characteristic of
particular tumor types, and not shared by all tumors. The degree
of nuclear contour irregularity observed in breast tumors
correlates with loss of progesterone receptor expression and with
disease progression [13]. Nuclear contour irregularities also
predict disease relapse in node negative breast cancer patients
[14].
Here we demonstrate that the BRG1 ATPase of an ATP
dependent chromatin remodeling enzyme has the capability of
regulating nuclear shape. Intriguingly, there are numerous
Figure 7. Induction of nuclear grooves after knockdown of
BRG1 does not depend on intact actin filaments. (A) Matched
individual confocal sections of representative fields of cells before and
after treatment with Latrunculin B at 0.2 mg/ml for 30 minutes. Actin
filaments were detected with Phalloidin-TRITC (red), while nuclei were
counterstained with the DNA dye DRAQ5 (blue). Size bar 10 mm. (B)
Quantification of nuclear grooves in control cells and cells treated with
Latrunculin B. The means for three counts of at least 100 nuclei scored
for grooves under each condition are presented +/2 standard
deviation. * represents p,0.05, *** represents p,0.005 as determined
by Student’s t-test.
doi:10.1371/journal.pone.0055628.g007
Figure 8. Induction of nuclear grooves after knockdown of
BRG1 does not depend on intact microtubules. (A) Matched
individual confocal sections of representative fields of cells before and
after treatment with Colcemid at 0.05 mg/ml for 3 hours. Microtubules
were detected with an a-Tubulin antibody (green), while nuclei were
counterstained with the DNA dye DRAQ5 (blue). Size bar 10 mm. (B)
Quantification of nuclear grooves in cells treated with Colcemid. The
means for three counts of at least 100 nuclei scored for grooves under
each condition are presented +/2 standard deviation. * represents
p,0.05, *** represents p,0.005 as determined by Student’s t-test.
doi:10.1371/journal.pone.0055628.g008
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connections between BRG1 and cancer. BRG1 deficient mice are
early-embryonic lethal but ,10% of BRG1 heterozygous mice
present with mammary tumors [9,11]. Primary human breast,
lung, pancreas, colon, and prostate tumor samples and/or cell
lines derived from such tumors have been reported to contain
BRG1 alleles that are deleted, mutated or silenced (reviewed in
[69,70]), further supporting the idea that BRG1 functions as a
tumor suppressor. However, other reports indicate that BRG1
expression is elevated in primary tumors and that BRG1
knockdown reduces cell proliferation [71–76]. The correlation
between inhibition of cell proliferation and BRG1 extends to non-
transformed cells as well [8,77]. Thus the requirement for BRG1
in cellular proliferation and cell transformation is complex and
may be context-dependent.
Similarly, the relationship between BRG1 and control of
nuclear shape is likely complex and may be context-dependent.
BRG1 knockdown in immortalized but non-transformed mam-
mary epithelial cells induces nuclear structural changes reminis-
cent of changes seen in tumors (Figures 1 and 2) yet was shown to
decrease cell proliferation [8]. BRG1 may therefore control the
delicate balance between hypo- and hyper-proliferative states.
However, there may be limits to the ability of BRG1 to maintain
this balance. The MDA-MB-231 cells generated from a metasta-
sized and drug-resistant breast tumor [38] had extremely distorted
nuclear profiles, and we did not see significant further alterations
after BRG1 reduction (Figure 4). While it may be that BRG1
effects on nuclear shape are lost after malignant transformation, it
is also possible that the perturbation of nuclear architecture in
MDA-MB-231 cells is already so severe that subtle additional
changes could not be distinguished.
Summary
We have shown that BRG1-dependent changes in nuclear
structure do not involve cytoskeletal tension mediated through
nuclear-cytoskeletal contacts. We propose that instead, alterations
in nuclear structure are generated from within the nucleus as a
result of deficiencies in normal chromatin remodeling and
organization by BRG1. Our results have implications in under-
standing the mechanisms involved in nuclear shape changes in
diseases such as laminopathies and cancer [12,15,16] as well as in
development [57,78].
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